• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂 SAHA 可减少营养不良小鼠的心律失常。

The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice.

机构信息

Laboratorio di Biologia Vascolare e Medicina Rigenerativa, Centro Cardiologico Monzino-IRCCS, Milano, Italy.

出版信息

Cardiovasc Res. 2010 Jul 1;87(1):73-82. doi: 10.1093/cvr/cvq035. Epub 2010 Feb 17.

DOI:10.1093/cvr/cvq035
PMID:20164117
Abstract

AIMS

The effect of histone deacetylase inhibitors on dystrophic heart function is not established. To investigate this aspect, dystrophic mdx mice and wild-type (WT) animals were treated 90 days either with suberoylanilide hydroxamic acid (SAHA, 5 mg/kg/day) or with an equivalent amount of vehicle.

METHODS AND RESULTS

The following parameters were evaluated: (i) number of ventricular arrhythmias in resting and stress conditions (restraint test) or after aconitine administration; (ii) cardiac excitability, conduction velocity, and refractoriness; (iii) expression and distribution of connexins (Cxs) and Na(v)1.5 sodium channel. Ventricular arrhythmias were negligible in all resting animals. During restraint, however, an increase in the number of arrhythmias was detected in vehicle-treated mdx mice (mdx-V) when compared with SAHA-treated mdx (mdx-SAHA) mice or normal control (WT-V). Interestingly, aconitine, a sodium channel pharmacologic opener, induced ventricular arrhythmias in 83% of WT-V mice, 11% of mdx-V, and in 57% of mdx-SAHA. Epicardial multiple lead recording revealed a prolongation of the QRS complex in mdx-V mice in comparison to WT-V and WT-SAHA mice, paralleled by a significant reduction in impulse propagation velocity. These alterations were efficiently counteracted by SAHA. Molecular analyses revealed that in mdx mice, SAHA determined Cx remodelling of Cx40, Cx37 and Cx32, whereas expression levels of Cx43 and Cx45 were unaltered. Remarkably, Cx43 lateralization observed in mdx control animals was reversed by SAHA treatment which also re-induced Na(v)1.5 expression.

CONCLUSION

SAHA attenuates arrhythmias in mdx mice by a mechanism in which Cx remodelling and sodium channel re-expression could play an important role.

摘要

目的

组蛋白去乙酰化酶抑制剂对营养不良性心脏功能的影响尚未确定。为了研究这一方面,用丁酸钠(SAHA,5mg/kg/天)或等量的载体处理 90 天的营养不良型 mdx 小鼠和野生型(WT)动物。

方法和结果

评估了以下参数:(i)静息和应激条件(束缚试验)或在乌头碱给药后室性心律失常的数量;(ii)心脏兴奋性、传导速度和不应期;(iii)连接蛋白(Cx)和 Na(v)1.5 钠通道的表达和分布。在所有静息动物中,室性心律失常都可以忽略不计。然而,在束缚期间,与 SAHA 处理的 mdx(mdx-SAHA)小鼠或正常对照(WT-V)相比,载体处理的 mdx 小鼠(mdx-V)的心律失常数量增加。有趣的是,乌头碱,一种钠离子通道药理学开放剂,在 83%的 WT-V 小鼠、11%的 mdx-V 小鼠和 57%的 mdx-SAHA 小鼠中引起室性心律失常。心外膜多导联记录显示,与 WT-V 和 WT-SAHA 小鼠相比,mdx-V 小鼠的 QRS 复合物延长,冲动传播速度显著降低。SAHA 有效地逆转了这些改变。分子分析表明,在 mdx 小鼠中,SAHA 确定了 Cx40、Cx37 和 Cx32 的 Cx 重塑,而 Cx43 和 Cx45 的表达水平没有改变。值得注意的是,SAHA 治疗逆转了 mdx 对照动物中观察到的 Cx43 侧化,同时也重新诱导了 Na(v)1.5 的表达。

结论

SAHA 通过 Cx 重塑和钠通道重新表达的机制减轻 mdx 小鼠的心律失常,这可能发挥重要作用。

相似文献

1
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice.组蛋白去乙酰化酶抑制剂 SAHA 可减少营养不良小鼠的心律失常。
Cardiovasc Res. 2010 Jul 1;87(1):73-82. doi: 10.1093/cvr/cvq035. Epub 2010 Feb 17.
2
Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment.肌营养不良症小鼠血浆差异表达蛋白的蛋白质组学特征及其在丁酸钠处理后的变化。
Proteomics Clin Appl. 2010 Jan;4(1):71-83. doi: 10.1002/prca.200900116. Epub 2009 Nov 11.
3
Reduced Na current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.浦肯野纤维钠离子电流减少导致杜氏肌营养不良症的心脏传导缺陷和心律失常。
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1436-H1440. doi: 10.1152/ajpheart.00224.2020. Epub 2020 May 8.
4
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.组蛋白去乙酰化酶抑制剂 SAHA 诱导乳腺癌细胞生长抑制,并增强紫杉醇诱导的细胞死亡。
Cancer Chemother Pharmacol. 2010 Nov;66(6):1131-40. doi: 10.1007/s00280-010-1455-1. Epub 2010 Sep 14.
5
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.伏立诺他,一种组蛋白去乙酰化酶抑制剂:对体外和体内胶质瘤细胞基因表达及生长的影响
Clin Cancer Res. 2007 Feb 1;13(3):1045-52. doi: 10.1158/1078-0432.CCR-06-1261.
6
Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.司立他汀和辛二酰苯胺异羟肟酸是组蛋白脱乙酰酶抑制剂,在体外具有强大的抗弓形虫活性。
J Parasitol. 2007 Jun;93(3):694-700. doi: 10.1645/GE-1043R.1.
7
Drug development for treatment of cardiac arrhythmias: targeting the gap junctions.用于治疗心律失常的药物研发:以缝隙连接为靶点。
Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H16-8. doi: 10.1152/ajpheart.01031.2007. Epub 2007 Sep 21.
8
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.伏立诺他,一种组蛋白去乙酰化酶抑制剂,在体外和体内均能抑制前列腺癌细胞的生长。
Cancer Res. 2000 Sep 15;60(18):5165-70.
9
Ranolazine in Cardiac Arrhythmia.雷诺嗪在心律失常中的应用
Clin Cardiol. 2016 Mar;39(3):170-8. doi: 10.1002/clc.22476. Epub 2015 Oct 13.
10
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.辛二酰苯胺异羟肟酸对组蛋白脱乙酰酶的药理学抑制作用特异性地改变基因表达并减轻小鼠脑缺血损伤。
Mol Pharmacol. 2006 Dec;70(6):1876-84. doi: 10.1124/mol.106.027912. Epub 2006 Aug 31.

引用本文的文献

1
HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease.组蛋白去乙酰化酶及其抑制剂对翻译后修饰的作用:心血管疾病的调控
Cells. 2025 Jul 20;14(14):1116. doi: 10.3390/cells14141116.
2
Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy.Fontan姑息治疗后单心室患者的比较代谢组学:靶向代谢治疗的有力证据
Metabolites. 2023 Aug 9;13(8):932. doi: 10.3390/metabo13080932.
3
Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies.
组蛋白去乙酰化酶:肌肉疾病的分子机制和治疗意义。
Int J Mol Sci. 2023 Feb 21;24(5):4306. doi: 10.3390/ijms24054306.
4
The intercalated disc: a unique organelle for electromechanical synchrony in cardiomyocytes.闰盘:心肌细胞中机电同步的独特细胞器。
Physiol Rev. 2023 Jul 1;103(3):2271-2319. doi: 10.1152/physrev.00021.2022. Epub 2023 Feb 2.
5
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development.心力衰竭中心脏纤维化和重构的新兴表观遗传学治疗方法:从基础机制到早期临床开发。
Cardiovasc Res. 2023 Feb 3;118(18):3482-3498. doi: 10.1093/cvr/cvac142.
6
Reduced Na current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.浦肯野纤维钠离子电流减少导致杜氏肌营养不良症的心脏传导缺陷和心律失常。
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1436-H1440. doi: 10.1152/ajpheart.00224.2020. Epub 2020 May 8.
7
Impact of oxidative posttranslational modifications of SERCA2 on heart failure exacerbation in young patients with non-ischemic cardiomyopathy: A pilot study.肌浆网钙ATP酶2的氧化翻译后修饰对非缺血性心肌病年轻患者心力衰竭加重的影响:一项初步研究。
Int J Cardiol Heart Vasc. 2019 Nov 14;26:100437. doi: 10.1016/j.ijcha.2019.100437. eCollection 2020 Feb.
8
Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart.电压依赖性肌质网离子通道异常在缺乏 dystrophin 的心脏中。
Int J Mol Sci. 2018 Oct 23;19(11):3296. doi: 10.3390/ijms19113296.
9
NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.NF-κB 抑制通过重塑杜氏肌营养不良症模型中的钙基因来挽救心脏功能。
Nat Commun. 2018 Aug 24;9(1):3431. doi: 10.1038/s41467-018-05910-1.
10
Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease.连接蛋白:在健康和疾病中的合成、翻译后修饰和运输。
Int J Mol Sci. 2018 Apr 26;19(5):1296. doi: 10.3390/ijms19051296.